Evidence map›Paper›PMID 42135647›Full record

ArticleBMC plant biology2026

Effects of exogenous polyamines and their synthesis inhibitors on the growth and development of blueberry fruits.

Wanru Han, Xinyu Zhang, Delu Wang

Abstract read
In one paragraph

Article in BMC plant biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wanru HanCollege of Forestry, Guizhou University, Huaxi, Guiyang, Guizhou, China.
Xinyu ZhangCollege of Forestry, Guizhou University, Huaxi, Guiyang, Guizhou, China.
Delu WangCollege of Forestry, Guizhou University, Huaxi, Guiyang, Guizhou, China. deluwang23@aliyun.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polyamines play crucial roles in fleshy fruit development, yet their regulatory effects on the morphological and cytological growth of blueberry (Vaccinium uliginosum L.) remain unclear. This study investigated the effects of exogenous polyamines-spermine (SPM), putrescine (PUT), and spermidine (SPD)-and their synthesis inhibitors (DArg and MGBG) at 0.1 mmol/L on blueberry fruit development. Morphological parameters and cytological microstructures (using paraffin sectioning) of the exocarp, mesocarp, and endocarp were quantitatively analyzed. Results showed that exogenous polyamines significantly promoted fruit growth without altering the typical double-sigmoid growth curve. Notably, SPM application exerted the most profound effect, significantly increasing the longitudinal diameter, transverse diameter, and single fruit weight by 8.23%, 11.29%, and 29.79%, respectively, compared to the control. Microscopic analysis revealed that SPM primarily facilitated fruit enlargement by synergistically promoting cell expansion (increasing cell area and layer thickness) in the exocarp, mesocarp, and endocarp, particularly during the late rapid growth phase. Conversely, polyamine synthesis inhibitors delayed early-stage growth but triggered late-stage compensatory expansion. Path analysis confirmed that flesh cell expansion, rather than cell division, was the dominant factor driving final fruit weight. These findings provide critical cytological evidence for understanding polyamine-mediated regulation and highlight SPM as a potential growth-promoting regulator in blueberry cultivation.

Indexed as

Blueberry PlantsFruitPolyaminesMitoguazonePutrescineSpermidineSpermineMitoguazonePolyaminesPutrescineSpermidineSpermineBlueberryFlesh cellsFruit developmentPolyamine

Identifiers

PMID42135647
PMCPMC13277275

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.